My Psychologist Diagnosed Me With “Major Depression” After Our First Session. He’s Insisting I Take Medication?

Question by .: My psychologist diagnosed me with “Major Depression” after our first session. He’s insisting I take medication?
He claims if i dont take medication that there is a “high risk” i will commit suicide?

Is this true of major depression? And what’s the difference between major depressio nand regular depression?

Best answer:

Answer by Andrew
I can’t speak on your mental state, but I have to say do a lot of research on the medication he prescribes for you. My mom was put through terrible withdrawals after she took a depression medication without knowing everything about it. It’s been a year since she’s been trying to come off of it and she’s still not all the way healed.

Answer by Viktor
Major depression and regular depression are the same thing. You should take the medication. Medication helps millions of people get out of depressions.

Also, check out “depression self help” and “natural cures” at www.depressiondodging.com for other ways that you can help yourself.

Best Way to Lose Weight Fast and Naturally
Link Here ? http://ProgramToLoseFat.com/FatLossGUARANTEED =)


 

 

Abbatis, Grow Life, Cannabis Science: Which Are the Best Marijuana Investments?
For example, Cannabis Science Inc. (OTCQB:CBIS) is developing novel cannabinoid-based therapies to improve patient lives; its CS-S/BCC1 topical cannabinoid is preparing to enter Phase I clinical studies for the treatment of skin cancer. Early studies … Read more on Wall St. Cheat Sheet

Global Omega-3 PUFAs Consumption Volume to Record 10% CAGR Through
… diabetes, depression, cognitive decline, among others. Pharmaceutical drugs have already begun to incorporate higher concentrations of omega-3. It is predicted that in the forthcoming years several novel companies will likely jump on to the … Read more on PR Web (press release)

Portage reports third quarter financial results and provides updates
Typically, there are only 30% remission rates with current first line antidepressant/anxiolytic treatments which leave a majority of patients with partial response or resistant depression/anxiety. The antidepressant market in the US is over $ 14 billion … Read more on Wall Street Journal